Blueweave
Spatial Genomics And Transcriptomics Market

Spatial Genomics And Transcriptomics Market

SPECIAL OFFER : 25% Super Discount For All !

Spatial Genomics and Transcriptomics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Technique (Spatial Transcriptomics, Spatial Genomics Analysis); By Product Type (Instruments, Consumables, Software); By Application (Translational Research, Drug Discovery & Development); By End Use (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: May 2023
  • Report ID: BWC23393
  • Available Format: PDF
  • Page: 400

Report Overview

A growing demand for personalized medicine and targeted therapeutics, rising investments in R&D activities in genomics and transcriptomics, and growing adoption of spatial genomics and transcriptomics in drug discovery and development processes are projected to propel the expansion of the global spatial genomics and transcriptomics market during the forecast period between 2023 and 2029.

Global Spatial Genomics and Transcriptomics Market - Industry Trends & Forecast Report, 2029

The global spatial genomics and transcriptomics market size was estimated at USD 199.46 million in 2022. During the forecast period between 2023 and 2029, the size of global spatial genomics and transcriptomics market is projected to grow at a CAGR of 11.35% reaching a value of USD 420.67 million by 2029. Major growth drivers for global spatial genomics and transcriptomics market include increasing demand for advanced tools that can provide more precise and detailed information about gene expression and cellular interactions. The global spatial genomics and transcriptomics market is expected to further experience significant growth in the coming years, due to the increasing demand for precision medicine and personalized treatments. Also, advances in single-cell sequencing technologies and the development of new spatial profiling methods are expected to drive the growth in this market.

Spatial Genomics and Transcriptomics Market

Global Spatial Genomics and Transcriptomics Market – Overview

Global spatial genomics and transcriptomics market refers to the use of advanced technologies that enable the visualization and analysis of gene expression patterns within intact tissues or cells. Spatial genomics and transcriptomics technologies provide high-resolution spatial information on gene expression patterns, allowing researchers to better understand the cellular and molecular mechanisms underlying complex biological processes. These technologies are used in a wide range of applications, including drug discovery, biomarker identification, and disease diagnosis. The market encompasses various products and services related to spatial genomics and transcriptomics, including instruments, reagents, software, and services for data analysis and interpretation.

Global Spatial Genomics and Transcriptomics Market

Growth Drivers

Increasing Investments in R&D of Genomics and Transcriptomics

With the increasing demand for precision medicine and personalized treatments, there has been a growing focus on developing new and advanced technologies that can provide more precise and detailed information about gene expression and cellular interactions. This has led to a surge in investments in R&D activities in genomics and transcriptomics, with many biotech and pharmaceutical companies investing heavily in developing new spatial profiling methods and single-cell sequencing technologies. Additionally, government organizations and academic institutions are also investing in genomics and transcriptomics research to advance the understanding of complex diseases and develop new treatments. These investments are expected to drive the growth of the global spatial genomics and transcriptomics market by enabling the development of new and more advanced technologies, as well as facilitating the adoption of these technologies in various applications. As a result, the market is expected to experience significant growth in the coming years, with increasing adoption of spatial genomics and transcriptomics technologies in drug discovery, biomarker identification, and disease diagnosis.

Restraints

Limited Awareness about Benefits of the Technology among End Users and Healthcare Professionals

The limited awareness among end users and healthcare professionals about the benefits is anticipated to restrain the global spatial genomics and transcriptomics market. When the potential users of these technologies are not aware of their benefits, they may not seek out the technology or invest in it, which can limit the growth of the market.

Impact of COVID-19 on Global Spatial Genomics and Transcriptomics Market

The COVID-19 pandemic had a dual impact on the global spatial genomics and transcriptomics market. The pandemic created a greater sense of urgency around the need for advanced genomics research to help combat the virus and develop effective treatments and vaccines. It drove increased funding and investments in the genomics sector overall, which could have positive spill-over effects for spatial genomics and transcriptomics. However, the pandemic also disrupted research activities and supply chains, which impacted the market growth. Laboratories and research facilities were shut down or operated at reduced capacity due to social distancing measures, which has slowed down the pace of research and development. Additionally, supply chain disruptions led to delays in the delivery of research reagents and other materials, which has further slowed down research activities. However, the market has rebounded after the pandemic, primarily due to the growing recognition of the advantages offered by spatial genomics and transcriptomics, leading to a wider acceptance and adoption of this technology.

Global Spatial Genomics and Transcriptomics Market

Segmental Coverage

Global Spatial Genomics and Transcriptomics Market – By Technique

By technique, the global spatial genomics and transcriptomics market is bifurcated into Spatial Transcriptomics and Spatial Genomics Analysis segments. The spatial transcriptomics segment held a higher market share primarily due to its widespread adoption in comparison to spatial genomic methods for studying single cells at the transcriptomic level. The growth of this segment can also be attributed to the availability of automated sequencing techniques, such as the laser capture microdissection (LCM) method, which has enabled the meeting of the increasing demand for nucleic acid sequencing of biological samples or single cells. The need for automated, robust, and scalable library preparation solutions has increased with the rise in nucleic acid sequencing of single cells or specific biological specimens. Additionally, several unique sequencing workflows have been introduced to infer or maintain spatial information, driven by an increased understanding of tissue heterogeneity, contributing to the growth of this segment. The spatial arrangement of molecules in cells and tissue samples is crucial for biological research and clinical practice, making it a focus area for various entities in the genetics field. The adoption of spatial genomic tools has also been propelled by advancements in genome perturbation tools, such as the CRISPR/Cas9 system, which has further contributed to the growth of this segment.

Global Spatial Genomics and Transcriptomics Market

Global Spatial Genomics and Transcriptomics Market – By Product Type

Based on end use, global spatial genomics and transcriptomics market is divided into Instruments, Consumables, and Software segments. The consumables segment held the highest market share in 2022 primarily due to its coverage of products that are essential for running instruments across various stages of genome mapping, ranging from sample preparation to result derivation. The high product penetration, wide availability of products, frequent purchase of consumables, and increased usage of reagents and kits to run the instruments have been key drivers of revenue flow in this segment. The growth of this segment is also dependent on any new instrument development or upgrades to existing instruments, as this will require the development of required consumables. The software segment is expected to experience significant growth, driven by the increasing volume of genomic research studies, which has created the need for robust software solutions for data management and interpretation. This is expected to fuel the growth of the segment in the coming years. Moreover, companies are expanding their service offerings to remain competitive in the market.

Spatial Genomics and Transcriptomics Market Share

Global Spatial Genomics and Transcriptomics Market – By Application

Based on application, the global spatial genomics and transcriptomics market is bifurcated into Translational Research and Drug Discovery & Development segments. The translational research segment held a higher share in the global spatial genomics and transcriptomics market due to high demand for targeted therapies and personalized medicine. Spatial genomics and transcriptomics technologies offer a more profound understanding of cell spatial arrangements and interactions, making it possible to identify new drug targets and develop therapies. The increasing investment in translational research by governments and private organizations has also boosted this segment's growth. The integration of these technologies into the translational research pipeline has led to the development of new diagnostics, therapeutics, and prognostic tools, further driving the segment's growth.

Spatial Genomics and Transcriptomics Market Size

Global Spatial Genomics and Transcriptomics Market – By End Use

Based on end use, the global spatial genomics and transcriptomics market is divided into Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic & Research Institutes segments. The academic & research institutes segment holds the highest share in the global spatial genomics and transcriptomics market. Academic & research institutes play a vital role in the advancement of basic scientific research in the genomics and transcriptomics fields, which are essential for the development of spatial genomics and transcriptomics technologies. Moreover, these institutes have access to skilled researchers, experts, and technicians who have the necessary expertise to operate and maintain the advanced equipment and instruments required for spatial genomics and transcriptomics research. Additionally, academic and research institutions have access to government funding, grants, and collaborations with industry partners, enabling them to undertake large-scale research projects and collaborations, thus driving the growth of this segment.

Global Spatial Genomics and Transcriptomics Market – By Region

The in-depth research report on the global spatial genomics and transcriptomics market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America holds the highest share in the global spatial genomics and transcriptomics market. The region has a well-established and advanced healthcare infrastructure, with leading research institutes, academic centers, and biotech companies involved in spatial genomics and transcriptomics research. Also, the region has a high adoption rate of new technologies and a high level of awareness among healthcare professionals and end users regarding the benefits of spatial genomics and transcriptomics. The presence of major market players and collaborations between academic institutions and industry players for research and development further drives the growth of this market in North America. The availability of government funding for R&D and increasing investments in genomics and transcriptomics research have contributed to the growth of the market in this region.

Competitive Landscape

Major players operating in global spatial genomics and transcriptomics market include 10x Genomics, Inc., NanoString Technologies, Inc., Fluidigm Corporation, Illumina, Inc., Spatial Transcriptomics AB, Akoya Biosciences, Inc., ReadCoor, Inc., Seven Bridges Genomics, Inc., Ultivue, Inc., S2 Genomics, Inc., Cartana AB, Zymo Research Corp., RareCyte, Inc., Bio-Techne Corporation, and Dolomite Bio Limited. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In April 2022 - 10x Genomics, a United States-based biotechnology company, introduced two sample prep kits to expand access to single-cell research.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Million

Market Coverage

North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)

Product/ Service Segmentation

Technique, Product Type, Application, End Use, Region

Key Players

10x Genomics, Inc., NanoString Technologies, Inc., Fluidigm Corporation, Illumina, Inc., Spatial Transcriptomics AB, Akoya Biosciences, Inc., ReadCoor, Inc., Seven Bridges Genomics, Inc., Ultivue, Inc., S2 Genomics, Inc., Cartana AB, Zymo Research Corp., RareCyte, Inc., Bio-Techne Corporation, Dolomite Bio Limited

 

By Technique

  • Spatial Transcriptomics

  • Spatial Genomics Analysis

By Product Type

  • Instruments

  • Consumables

  • Software

By Application

  • Translational Research

  • Drug Discovery & Development

By End Use

  • Pharmaceutical & Biotechnology Companies

  • Contract Research Organizations

  • Academic & Research Institutes

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America

  • Middle East and Africa (MEA)

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3.  Global Spatial Genomics and Transcriptomics Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Growing demand for personalized medicine and targeted therapeutics
        2. Rising investments in research and development activities in genomics and transcriptomics
        3. Growing adoption of spatial genomics and transcriptomics in drug discovery and development processes
      2. Restraints
        1. Limited awareness among End Users and healthcare professionals about the benefits
        2. Limited availability of infrastructure and resources in developing countries
      3. Opportunities
        1. Development of new applications for spatial genomics and transcriptomics in non-invasive prenatal testing
        2. Collaborations and partnerships between research institutions, academia, and industry players
      4. Challenges
        1. Ethical and legal issues related to genomics and transcriptomics research and use
    3. Technology Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4.  Global Spatial Genomics and Transcriptomics Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share and Forecast
      1. By Technique
        1. Spatial Transcriptomics
        2. Spatial Genomics Analysis
      2. By Product Type
        1. Instruments
        2. Consumables
        3. Software
      3. By Application
        1. Translational Research
        2. Drug Discovery & Development
      4. By End Use
        1. Pharmaceutical & Biotechnology Companies
        2. Contract Research Organizations
        3. Academic & Research Institutes
        4. Others
      5. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  5. North America Spatial Genomics and Transcriptomics Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
      5. By Country
        1. United States
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        2. Canada
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
  6. Europe Spatial Genomics and Transcriptomics Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
      5. By Country
        1. Germany
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        2. United Kingdom
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        3. Italy
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        4. France
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        5. Spain
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        6. Belgium
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        7. Russia
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        8. The Netherlands
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        9. Rest of Europe
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
  7. Asia-Pacific Spatial Genomics and Transcriptomics Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
      5. By Country
        1. China
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        2. India
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        3. Japan
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        4. South Korea
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        5. Australia & New Zealand
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        6. Indonesia
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        7. Malaysia
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        8. Singapore
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        9. Vietnam
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        10. Rest of APAC
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
  8. Latin America Spatial Genomics and Transcriptomics Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
      5. By Country
        1. Brazil
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        2. Mexico
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        3. Argentina
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        4. Peru
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        5. Rest of LATAM
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
  9. Middle East & Africa Spatial Genomics and Transcriptomics Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
      5. By Country
        1. Saudi Arabia
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        2. UAE
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        3. Qatar
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        4. Kuwait
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        5. South Africa
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        6. Nigeria
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        7. Algeria
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
        8. Rest of MEA
          1. By Technique
          2. By Product Type
          3. By Application
          4. By End Use
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Spatial Genomics and Transcriptomics Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Covid-19 on Global Spatial Genomics and Transcriptomics Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. 10x Genomics, Inc.
    2. NanoString Technologies, Inc.
    3. Fluidigm Corporation
    4. Illumina, Inc.
    5. Spatial Transcriptomics AB
    6. Akoya Biosciences, Inc.
    7. ReadCoor, Inc.
    8. Seven Bridges Genomics, Inc.
    9. Ultivue, Inc.
    10. S2 Genomics, Inc.
    11. Cartana AB
    12. Zymo Research Corp.
    13. RareCyte, Inc.
    14. Bio-Techne Corporation
    15. Dolomite Bio Limited
    16. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1.   Qualitative Research
      1.  Primary & Secondary Research
    2.   Quantitative Research
    3.   Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.   Breakdown of Primary Research Respondents, By Region
    5.   Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

 

List of Figures

Figure 1       Global Spatial Genomics and Transcriptomics Segmentation

Figure 2       Global Spatial Genomics and Transcriptomics Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2022

Figure 4       Global Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 5       Global Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 6       Global Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 7       Global Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 8       Global Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 9       Global Spatial Genomics and Transcriptomics Market Share, By Region, By Value, 2019–2029

Figure 10     North America Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 11     North America Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 12     North America Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 13     North America Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 14     North America Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 15     North America Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Figure 16     United States Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 17     United States Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 18     United States Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 19     United States Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 20     United States Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 21     Canada Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 22     Canada Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 23     Canada Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 24     Canada Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 25     Canada Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 26     Europe Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 27     Europe Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 28     Europe Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 29     Europe Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 30     Europe Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 31     Europe Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Figure 32     Germany Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 33     Germany Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 34     Germany Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 35     Germany Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 36     Germany Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 37     United Kingdom Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 38     United Kingdom Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 39     United Kingdom Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 40     United Kingdom Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 41     United Kingdom Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 42     Italy Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 43     Italy Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 44     Italy Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 45     Italy Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 46     Italy Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 47     France Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 48     France Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 49     France Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 50     France Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 51     France Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 52     Spain Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 53     Spain Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 54     Spain Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 55     Spain Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 56     Spain Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 57     Belgium Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 58     Belgium Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 59     Belgium Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 60     Belgium Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 61     Belgium Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 62     Russia Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 63     Russia Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 64     Russia Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 65     Russia Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 66     Russia Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 67     The Netherlands Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 68     The Netherlands Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 69     The Netherlands Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 70     The Netherlands Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 71     The Netherlands Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 72     Rest of Europe Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 73     Rest of Europe Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 74     Rest of Europe Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 75     Rest of Europe Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 76     Rest of Europe Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 77     Asia-Pacific Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 78     Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 79     Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 80     Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 81     Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 82     Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Figure 83     China Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 84     China Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 85     China Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 86     China Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 87     China Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 88     India Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 89     India Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 90     India Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 91     India Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 92     India Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 93     Japan Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 94     Japan Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 95     Japan Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 96     Japan Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 97     Japan Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 98     South Korea Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 99     South Korea Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 100   South Korea Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 101   South Korea Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 102   South Korea Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 103   Australia & New Zealand Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 104   Australia & New Zealand Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 105   Australia & New Zealand Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 106   Australia & New Zealand Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 107   Australia & New Zealand Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 108   Indonesia Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 109   Indonesia Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 110   Indonesia Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 111   Indonesia Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 112   Indonesia Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 113   Malaysia Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 114   Malaysia Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 115   Malaysia Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 116   Malaysia Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 117   Malaysia Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 118   Singapore Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 119   Singapore Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 120   Singapore Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 121   Singapore Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 122   Singapore Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 123   Vietnam Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 124   Vietnam Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 125   Vietnam Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 126   Vietnam Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 127   Vietnam Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 128   Rest of APAC Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 129   Rest of APAC Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 130   Rest of APAC Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 131   Rest of APAC Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 132   Rest of APAC Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 133   Latin America Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 134   Latin America Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 135   Latin America Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 136   Latin America Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 137   Latin America Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 138   Latin America Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Figure 139   Brazil Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 140   Brazil Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 141   Brazil Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 142   Brazil Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 143   Brazil Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 144   Mexico Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 145   Mexico Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 146   Mexico Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 147   Mexico Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 148   Mexico Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 149   Argentina Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 150   Argentina Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 151   Argentina Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 152   Argentina Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 153   Argentina Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 154   Peru Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 155   Peru Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 156   Peru Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 157   Peru Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 158   Peru Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 159   Rest of LATAM Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 160   Rest of LATAM Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 161   Rest of LATAM Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 162   Rest of LATAM Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 163   Rest of LATAM Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 164   Middle East & Africa Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 165   Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 166   Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 167   Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 168   Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 169   Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Figure 170   Saudi Arabia Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 171   Saudi Arabia Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 172   Saudi Arabia Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 173   Saudi Arabia Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 174   Saudi Arabia Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 175   UAE Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 176   UAE Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 177   UAE Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 178   UAE Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 179   UAE Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 180   Qatar Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 181   Qatar Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 182   Qatar Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 183   Qatar Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 184   Qatar Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 185   Kuwait Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 186   Kuwait Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 187   Kuwait Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 188   Kuwait Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 189   Kuwait Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 190   South Africa Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 191   South Africa Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 192   South Africa Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 193   South Africa Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 194   South Africa Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 195   Nigeria Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 196   Nigeria Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 197   Nigeria Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 198   Nigeria Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 199   Nigeria Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 200   Algeria Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 201   Algeria Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 202   Algeria Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 203   Algeria Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 204   Algeria Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 205   Rest of MEA Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 206   Rest of MEA Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 207   Rest of MEA Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 208   Rest of MEA Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 209   Rest of MEA Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

 

 

List of Tables

 

Table 1 Global Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 2 Global Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 3 Global Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 4 Global Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 5 Global Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 6 Global Spatial Genomics and Transcriptomics Market Share, By Region, By Value, 2019–2029

Table 7 North America Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 8 North America Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 9 North America Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 10      North America Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 11      North America Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 12      North America Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Table 13      United States Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 14      United States Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 15      United States Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 16      United States Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 17      United States Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 18      Canada Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 19      Canada Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 20      Canada Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 21      Canada Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 22      Canada Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 23      Europe Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 24      Europe Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 25      Europe Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 26      Europe Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 27      Europe Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 28      Europe Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Table 29      Germany Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 30      Germany Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 31      Germany Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 32      Germany Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 33      Germany Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 34      United Kingdom Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 35      United Kingdom Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 36      United Kingdom Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 37      United Kingdom Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 38      United Kingdom Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 39      Italy Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 40      Italy Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 41      Italy Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 42      Italy Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 43      Italy Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 44      France Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 45      France Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 46      France Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 47      France Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 48      France Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 49      Spain Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 50      Spain Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 51      Spain Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 52      Spain Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 53      Spain Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 54      Belgium Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 55      Belgium Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 56      Belgium Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 57      Belgium Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 58      Belgium Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 59      Russia Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 60      Russia Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 61      Russia Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 62      Russia Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 63      Russia Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 64      The Netherlands Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 65      The Netherlands Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 66      The Netherlands Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 67      The Netherlands Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 68      The Netherlands Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 69      Rest of Europe Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 70      Rest of Europe Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 71      Rest of Europe Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 72      Rest of Europe Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 73      Rest of Europe Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 74      Asia-Pacific Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 75      Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 76      Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 77      Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 78      Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 79      Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Table 80      China Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 81      China Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 82      China Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 83      China Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 84      China Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 85      India Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 86      India Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 87      India Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 88      India Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 89      India Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 90      Japan Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 91      Japan Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 92      Japan Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 93      Japan Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 94      Japan Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 95      South Korea Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 96      South Korea Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 97      South Korea Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 98      South Korea Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 99      South Korea Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 100    Australia & New Zealand Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 101    Australia & New Zealand Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 102    Australia & New Zealand Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 103    Australia & New Zealand Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 104    Australia & New Zealand Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 105    Indonesia Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 106    Indonesia Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 107    Indonesia Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 108    Indonesia Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 109    Indonesia Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 110    Malaysia Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 111    Malaysia Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 112    Malaysia Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 113    Malaysia Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 114    Malaysia Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 115    Singapore Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 116    Singapore Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 117    Singapore Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 118    Singapore Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 119    Singapore Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 120    Vietnam Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 121    Vietnam Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 122    Vietnam Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 123    Vietnam Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 124    Vietnam Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 125    Rest of APAC Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 126    Rest of APAC Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 127    Rest of APAC Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 128    Rest of APAC Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 129    Rest of APAC Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 130    Latin America Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 131    Latin America Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 132    Latin America Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 133    Latin America Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 134    Latin America Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 135    Latin America Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Table 136    Brazil Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 137    Brazil Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 138    Brazil Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 139    Brazil Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 140    Brazil Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 141    Mexico Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 142    Mexico Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 143    Mexico Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 144    Mexico Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 145    Mexico Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 146    Argentina Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 147    Argentina Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 148    Argentina Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 149    Argentina Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 150    Argentina Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 151    Peru Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 152    Peru Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 153    Peru Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 154    Peru Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 155    Peru Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 156    Rest of LATAM Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 157    Rest of LATAM Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 158    Rest of LATAM Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 159    Rest of LATAM Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 160    Rest of LATAM Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 161    Middle East & Africa Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 162    Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 163    Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 164    Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 165    Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 166    Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Table 167    Saudi Arabia Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 168    Saudi Arabia Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 169    Saudi Arabia Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 170    Saudi Arabia Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 171    Saudi Arabia Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 172    UAE Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 173    UAE Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 174    UAE Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 175    UAE Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 176    UAE Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 177    Qatar Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 178    Qatar Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 179    Qatar Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 180    Qatar Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 181    Qatar Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 182    Kuwait Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 183    Kuwait Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 184    Kuwait Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 185    Kuwait Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 186    Kuwait Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 187    South Africa Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 188    South Africa Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 189    South Africa Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 190    South Africa Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 191    South Africa Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 192    Nigeria Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 193    Nigeria Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 194    Nigeria Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 195    Nigeria Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 196    Nigeria Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 197    Algeria Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 198    Algeria Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 199    Algeria Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 200    Algeria Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 201    Algeria Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 202    Rest of MEA Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 203    Rest of MEA Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 204    Rest of MEA Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 205    Rest of MEA Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 206    Rest of MEA Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 207    10x Genomics, Inc. Company Overview

Table 208    10x Genomics, Inc. Financial Overview

Table 209    NanoString Technologies, Inc.   Company Overview

Table 210    NanoString Technologies, Inc.   Financial Overview

Table 211    Fluidigm Corporation       Company Overview

Table 212    Fluidigm Corporation       Financial Overview

Table 213    Illumina, Inc.         Company Overview

Table 214    Illumina, Inc.         Financial Overview

Table 215    Spatial Transcriptomics AB         Company Overview

Table 216    Spatial Transcriptomics AB         Financial Overview

Table 217    Akoya Biosciences, Inc.    Company Overview

Table 218    Akoya Biosciences, Inc.    Financial Overview

Table 219    ReadCoor, Inc.       Company Overview

Table 220    ReadCoor, Inc.       Financial Overview

Table 221    Seven Bridges Genomics, Inc.    Company Overview

Table 222    Seven Bridges Genomics, Inc.    Financial Overview

Table 223    Ultivue, Inc. Company Overview

Table 224    Ultivue, Inc. Financial Overview

Table 225    S2 Genomics, Inc.  Company Overview

Table 226    S2 Genomics, Inc.  Financial Overview

Table 227    Cartana AB   Company Overview

Table 228    Cartana AB   Financial Overview

Table 229    Zymo Research Corp.      Company Overview

Table 230    Zymo Research Corp.      Financial Overview

Table 231    RareCyte, Inc.       Company Overview

Table 232    RareCyte, Inc.       Financial Overview

Table 233    Bio-Techne Corporation   Company Overview

Table 234    Bio-Techne Corporation   Financial Overview

Table 235    Dolomite Bio Limited        Company Overview

Table 236    Dolomite Bio Limited        Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Major factors driving the growth of Global Spatial Genomics and Transcriptomics Market include growing demand for personalized medicine and targeted therapeutics, rising investments in research and development activities in genomics and transcriptomics, and growing adoption of spatial genomics and transcriptomics in drug discovery and development processes.
Ans: Global Spatial Genomics and Transcriptomics Market size was estimated at USD 199.46 million in 2022.
Ans: The spatial transcriptomics segment is expected to hold a higher market share in the Global Spatial Genomics and Transcriptomics Market by technique.
Ans: The consumables segment is expected to hold the highest market share in the Global Spatial Genomics and Transcriptomics Market by product type.
Ans: Key players in the Global Spatial Genomics and Transcriptomics Market include 10x Genomics, Inc., NanoString Technologies, Inc., Fluidigm Corporation, Illumina, Inc., Spatial Transcriptomics AB, Akoya Biosciences, Inc., ReadCoor, Inc., Seven Bridges Genomics, Inc., Ultivue, Inc., S2 Genomics, Inc., Cartana AB, Zymo Research Corp., RareCyte, Inc., Bio-Techne Corporation, and Dolomite Bio Limited.